ID: ALA4592672

Max Phase: Preclinical

Molecular Formula: C59H115N9O10S

Molecular Weight: 1142.69

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCCCOC(=O)NCCSC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O

Standard InChI:  InChI=1S/C59H115N9O10S/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-35-44-78-59(77)63-43-45-79-47-52(64-53(70)39-28-26-24-22-20-18-16-14-12-10-8-6-4-2)57(74)68-51(46-69)56(73)66-48(36-29-32-40-60)54(71)65-49(37-30-33-41-61)55(72)67-50(58(75)76)38-31-34-42-62/h48-52,69H,3-47,60-62H2,1-2H3,(H,63,77)(H,64,70)(H,65,71)(H,66,73)(H,67,72)(H,68,74)(H,75,76)/t48-,49-,50-,51+,52-/m0/s1

Standard InChI Key:  GVUGRBXCTKIEHM-DLMHBMBKSA-N

Associated Targets(Human)

Toll-like receptor 1/2 401 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BV-2 3710 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Toll-like receptor 2 148 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1142.69Molecular Weight (Monoisotopic): 1141.8488AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Du X, Qian J, Wang Y, Zhang M, Chu Y, Li Y..  (2019)  Identification and immunological evaluation of novel TLR2 agonists through structure optimization of Pam3CSK4.,  27  (13): [PMID:31101493] [10.1016/j.bmc.2019.05.005]

Source